In Africa, pregnant women and young children are the most vulnerable to malaria.

However, malaria control interventions and strategies have achivied important results in the last years.

COVID-19 has now made these interventions critical, and could undo the results obtained so far, as highlighted by scientists in the Lancet: https://bit.ly/2Tfyxwn.

Potentially, COVID-19 could indirectly cause more deaths than it already does directly, in the context of Africa’s weak and fragile health systems.

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

Response to Covid-19 in Africa

The impact of Covid-19 in Africa is a ticking bomb on which the European Union (EDCTP) intervenes by supporting research projects. In response to this, a consortium of African and

Driving Impact and Collaboration: NeuroSolve 2026 Annual Meeting in Morogoro

On the last 30th and 31st of May, R-Evolution Worldwide lead the second Annual Meeting of NeuroSolve, our coordinated project aiming to address the burden of neurocysticercosis and improve the

The Congolese National Medicines Regulatory Authority (DPM) with WHO to guarantee the development and circulation of safe and effective drugs, by implementing the Global Benchmarking Tool (GBT)

As part of the strengthening of health systems and in particular the regulation of drugs and health products within the Africlinique project, the headquarters of the World Health Organization (WHO),